Goldman Sachs Group Inc (GS) stock saw a decline, ending the day at $636.9 which represents a decrease of $-2.60 or -0.41% from the prior close of $639.5. The stock opened at $630 and touched a low of $628.

UBS analyst Thomas Wadewitz revised the price target on JetBlue Airways (NASDAQ:JBLU) shares, reducing it to $5.00 from the previous target of $5.50. Despite the adjustment, the firm continues to recommend a Sell rating for the airline's stock.

Goldman Sachs and UBS have emerged as the leading mergers and acquisitions (M&A) financial advisers in South America for 2024, in terms of deal value and volume, respectively, according to the latest league table from GlobalData, a data and analytics firm.

UBS analyst Brennan Hawken raised the firm’s price target on Goldman Sachs (GS) to $640 from $610 and keeps a Neutral rating on the shares. The

The Goldman Sachs Group (NYSE:GS – Free Report) had its target price increased by UBS Group from $610.00 to $640.00 in a report issued on Tuesday morning,Benzinga reports.UBS Group currently has ...

Goldman Sachs CEO David Solomon promoted a slew of top bankers on Tuesday to run the firm’s biggest business units, just days after the bank boss was awarded a pair of massive bonuses. The

Interactive Brokers Group (NASDAQ:IBKR – Get Free Report) had its target price boosted by stock analysts at UBS Group from $225.00 to $265.00 in a note issued to investors on Monday,Benzinga reports.

India and the U.S. are plugging a hole in the market for steel-making coal caused by declining demand in China which has in turn opened opportunities for investors.

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share price rises for companies including Telix Pharmaceuticals, Clarity Pharmaceuticals and earlier-stage PYC Therapeutics.

IndiGo, whose December quarter results were marred by foreign exchange losses, remained on the buy list of UBS and Goldman Sachs, even as the two brokerages differed on the price target for the airline's stock. UBS has raised the 12-month price target for ...

We recently compiled a list of the 35 Most Important AI Stocks for 2025 According to JPMorgan. In this article, we are going to take a look at where Celestica Inc.

UBS lowered the firm’s price target on Bright Horizons (BFAM) to $130 from $148 and keeps a Neutral rating on the shares. UBS expects an in-line Q4, with 2025 EPS guidance possibly ahead of ...